+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibition of mammary carcinogenesis in the rat by a new vitamin D analog



Inhibition of mammary carcinogenesis in the rat by a new vitamin D analog



Proceedings of the American Association for Cancer Research Annual Meeting 34: 128




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031949001

Download citation: RISBibTeXText


Related references

A novel vitamin D analog, 1-alpha, hydroxy vitamin D-5, as a potential chemopreventive agent against mammary carcinogenesis. International Journal of Oncology 7(Suppl. ): 979, 1995

Vitamin D analog synergizes with tamoxifen in prevention of mammary carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 35: 623, 1994

Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D. Mutation Research 523-524: 253-264, 2003

Inhibition of mammary carcinogenesis in rats by parenteral high-dose vitamin E. Journal of the National Cancer Institute 89(13): 972-973, 1997

Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling. Journal of Steroid Biochemistry and Molecular Biology 121(1-2): 408-412, 2010

Whole-food sources of vitamin A more effectively inhibit female rat sexual maturation, mammary gland development, and mammary carcinogenesis than retinyl palmitate. Journal of Nutrition 137(6): 1415-1422, 2007

In vivo inhibition of mammary carcinogenesis, formation of DNA-carcinogen adducts, and mammary gland proliferation by dietary dibenzoylmethane. Abstracts of Papers American Chemical Society 221(1-2): AGFD 24, 2001

Elevated expression of P27 in mammary gland by caloric restriction and corticosterone administration Possible role in CR mediated inhibition of mammary carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 39: 115, 1998

Inhibition of benzo(a)pyrene-induced carcinogenesis by vitamin C alone and by vitamin C/vitamin E and selenium/glutathione. Biological Trace Element Research 93(1-3): 201-212, 2003

MNU-induced mammary gland carcinogenesis: chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways. Toxicology Letters 207(1): 60-72, 2012

Preventive effects of a pure antiestrogen and a gonadotropin-releasing hormone analog in rat mammary carcinogenesis. Breast Cancer Research & Treatment 32(Suppl. ): 68, 1994

Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis. Anticancer Research 21(6a): 3839-3844, 2002

Antipromotional effects of a pure antiestrogen and a gonadotropin-releasing hormone analog in rat mammary carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 35: 186, 1994

Inhibition of 7 12 dimethylbenz a anthracene induced mammary tumorigenicity by cyclic amp analogs and tamoxifen involves depression of p 21 ras protein level of mammary glands at the initiation of carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 27: 126, 1986

Sex hormone-induced mammary carcinogenesis in female Noble rats: expression of TGF-beta1 and its receptors, TGF-alpha, and EGF-R in mammary carcinogenesis. Breast Cancer Research and Treatment 58(3): 227-239, 2000